Market Overview

UPDATE: CVS Caremark Posts Higher Q4 Earnings

Share:
Related CVS
CVS Health Says Overdose-Reversal Drug Is Now Available Without A Prescription In Texas
Barron's Picks And Pans: Pharmacy-Benefit Managers, Mortgage Insurers And More
Focus On Quality For Long-Term Success (Seeking Alpha)

CVS Caremark (NYSE: CVS) reported a rise in its fourth-quarter earnings.

CVS Caremark's quarterly profit climbed to $1.13 billion, or $0.90 per share, from $1.1 billion, or $0.81 per share, in the year-ago period. Excluding one-time items, its adjusted earnings from continuing operations came in at $1.14 per share.

Its revenue rose 11% to $31.39 billion. However, analysts were expecting earnings of $1.10 per share on revenue of $31.13 billion.

CVS Caremark shares gained 1.80% to $52.65 in pre-market trading.

Posted-In: profitEarnings News

 

Related Articles (CVS)

View Comments and Join the Discussion!